1075-28-1

Basic information

• Product Name: Benzene, 1-bromo-2-(3-bromopropyl)-
• CAS NO: 1075-28-1
• Molecular Formula: C9H10Br2
• Molecular Weight: 277.986
• Mol File: 1075-28-1.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: Benzene, 1-bromo-2-(3-bromopropyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, 1-bromo-2-(3-bromopropyl)-(1075-28-1)
• EPA Substance Registry System: Benzene, 1-bromo-2-(3-bromopropyl)-(1075-28-1)

Safety Data

• Hazardous Substances Data: 1075-28-1(Hazardous Substances Data)

Upstream product

• 52221-92-8 3-(2-bromo-phenyl)-propan-1-ol 
• 95-46-5 2-methylphenyl bromide 
• 15115-58-9 3-(2-bromophenyl)propionic acid 
• 3433-80-5 1-Bromo-2-bromomethyl-benzene 
• 42918-20-7 1-allyl-2-bromobenzene 
• 6630-33-7 ortho-bromobenzaldehyde 

Downstream Products

• 177324-09-3 3-(2-bromophenyl)propyl methyl ether 
• 17908-94-0 1-phenyl-1,2,3,4-tetrahydro-benzo[b]siline 
• 19614-14-3 1-bromo-2-propylbenzene 
• 123206-83-7 4-(2-Bromophenyl)-1-butanol 
• 1000014-26-5 1-bromo-3-[2-(trimethylsilylethynyl)phenyl]propane 
• 1231-12-5 2,3-Benzo-1,1-diphenyl-1-stanna-cyclohex-2-en 
• 1174289-67-8 [3-(2-bromophenyl)propyl](triphenyl)phosphonium bromide 
• 1207957-96-7 C₂₅H₂₁BrN₄O 
• 178809-32-0 4-(2-bromophenyl)butanenitrile 

Relevant articles and documents

Iridium-Catalyzed Cycloisomerization of Alkynoic Acids: Synthesis of Unsaturated Lactones

The iridium-catalyzed cycloisomerization of various alkynoic acids was successfully developed, and a series of five-, six-, and especially seven-membered unsaturated lactones were constructed with moderate yields and excellent regioselectivities (up to 68

Expedient Access to 2-Benzazepines by Palladium-Catalyzed C?H Activation: Identification of a Unique Hsp90 Inhibitor Scaffold

Bioactive 2-benzazepines were accessed in an atom- and step-economical manner through a versatile palladium-catalyzed C?H activation strategy. The C?H arylation required low catalyst loading and a mild base, which was reflected by a broad scope and high functional-group tolerance. The benzotriazolodiazepinones were identified as new heat shock protein 90 (Hsp90) inhibiting lead compounds, with considerable potential for anti-cancer applications.

Modulators of Cystic Fibrosis Transmembrane Conductance Regulator

The present invention features a compound of formula I: or a pharmaceutically acceptable salt thereof, where R1, R2, R3, W, X, Y, Z, n, o, p, and q are defined herein, for the treatment of CFTR mediated diseases, such as cystic fibrosis. The present invention also features pharmaceutical compositions, method of treating, and kits thereof.